Cerner (NASDAQ:CERN) Rating Reaffirmed
The broker has just set a target price per share of $70.0 on Cerner (NASDAQ:CERN) shares. This is 16.36% from the last stock close. In an interesting research report sent to investors on Wednesday, 2 December, RBC Capital Mkts has decided to reaffirm their “Outperform” rating on shares of CERN.
From a total of 25 analysts covering Cerner Corporation (NASDAQ:CERN) stock, 24 rate it a ”Buy”, 1 a “Sell”, and 3 a ”Hold”. This means that 86% of the ratings are positive. The highest target price is $82 while the lowest target price is $48. The mean of all analyst targets is $69.78 with a 18.40% above today’s ($60.16) stock price. Cerner Corporation was the topic of 23 analyst reports since August 5, 2015 according to the firm StockzIntelligence Inc. Deutsche Bank maintained shares on November 10 with “Buy” rating. Topeka Capital Markets upgraded shares to “Buy” rating and $71 target share price in a report from a September 8. Avondale initiated CERN stock in a recent report from October 21 with “Market Outperform” rating. Finally, RBC Capital Markets upgraded the stock to “Outperform” rating in a report issued on a September 29.
The stock increased 0.94% or $0.56 during the last trading session, striking $60.16. Approximately shares of stock traded hands. Cerner Corporation (NASDAQ:CERN) has declined 17.62% since April 29, 2015 and is downtrending. It has underperformed by 17.42% the S&P500.
Cerner Corporation is a supplier of health care information technology (HCIT). The company has a market cap of $20.39 billion. The Firm offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations. It has 40.56 P/E ratio. The Firm offers software, hardware, professional services and managed services.
According to Zacks Investment Research, “Cerner Corp. designs, develops, markets, installs and supports information technology and content solutions for healthcare organizations and consumers that are capable of being implemented on an individual, combined or enterprise-wide basis and are accessible over the internet by consumers, physicians and healthcare providers. Cerner’s integrated suite of solutions enable healthcare providers to improve operating effectiveness, reduce costs and improve the quality of care as measured by clinical outcomes.” Get a free copy of the Zacks research report on Cerner Corporation (CERN).